110392 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae Human Immunodeficiency Virus, HIV
Sub-classes:VCN ENHANCER COMPOSITIONS AND METHODS OF USING THE SAME
#2POLYNUCLEOTIDES ENCODING LINKED ANTIGENS AND USES THEREOF
#3Enhanced expression of polo-like kinase 3 (PLK3) in human immunodeficiency virus (HIV)-infected cells
#4Method of inhibiting HIV-1 viral rebound in a subject using interferon inhibitors and ART
#5Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
#6Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof
#7Therapeutic retroviral vectors for gene therapy
#8THERAPEUTIC FORMULATIONS CONTAINING CD34+ STEM CELLS DERIVED FROM NEGATIVE SELECTION
#9Compounds that bind to human immunodeficiency virus rev response element
#10Method for detecting HIV-1 co-receptor tropism
#11VCN enhancer compositions and methods of using the same
#12Lentiviral vectors for expression of hepatitis B virus (HBV) antigens
#13Therapeutic retroviral vectors for gene therapy
#14COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
#15TREATMENT OF CANCERS WITH IMMUNOSTIMULATORY HIV TAT DERIVATIVE POLYPEPTIDES
#16HIV VIRAL LOAD TESTING
#17Compositions and methods for self-adjuvanting vaccines against microbes and tumors
#18METHODS AND COMPOSITIONS FOR TREATMENT OF MITOCHONDRIAL DISORDERS
#19Lentiviral protein delivery system for RNA-guided genome editing
#20Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodies
#21COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
#22Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof
#23Neutralizing antibodies to HIV-1 and their use
#24Compositions and methods for self-adjuvanting vaccines against microbes and tumors
#25Treatment of cancers with immunostimulatory HIV Tat derivative polypeptides
#26IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions
#27Recombinant IgG4 monovalent antibodies
#28COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE
#29Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors
#30Compounds that bind to human immunodeficiency virus rev response element
#31Compositions and methods for the identification of inhibitors of retroviral infection
#32Dual-color HIV reporter system for the detection of latently-infected cells
#33Apparatus and method for automated sample preparation and adaptor for use in the apparatus
#34HIV viral load testing
#35Therapeutic retroviral vectors for gene therapy
#36Gene editing for HIV gene therapy
#37Neutralizing antibodies to HIV-1 and their use
#38Treatment of cancers with immunostimulatory HIV tat derivative polypeptides
#39Glycopeptide and uses thereof
#40Method for quantitating total HMGB1 protein in biological samples
#41Vaccination with immuno-isolated cells producing an immunomodulator
#42Glycopeptide and uses thereof
#43Compositions and methods for the identification of inhibitors of retroviral infection
#44Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence
#45Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence
#46Chemically Programmed Vaccination
#47Compositions and methods for self-adjuvanting vaccines against microbes and tumors
#48Monoclonal antibodies directed against the human immunodeficiency virus type 1 (hiv-1) P17 matrix (ma) protein
#49Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
#50Neutralizing antibodies to HIV-1 and their use
#51COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
#52NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE
#53Neutralizing antibodies to HIV-1 and their use
#54Method of inducing neutralizing antibodies to human immunodeficiency virus
#55Polynucleotides encoding a human TRIM-Cyp fusion polypeptide, compositions thereof, and methods of using same
#56Combination anti-HIV vectors, targeting vectors, and methods of use
#57HIV-1-C RESISTANCE MONITORING
#58GLYCOPEPTIDE AND USES THEREOF
#59HIV DNA vaccine methods of use
#60DNA vaccine compositions with HIV/SIV gene modifications
#61Therapeutic retroviral vectors for gene therapy
#62Chemically programmed vaccination
#63Methods for the reactivation of latent HIV using cytosine methylation inhibitors and NF-KB activators
#64THERAPEUTIC RETROVIRAL VECTORS FOR GENE THERAPY
#65Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence
#66METHODS AND COMPOSITIONS FOR TREATMENT OF MITOCHONDRIAL DISORDERS
#67Methods, agents and peptides for inducing an innate immune response in HIV vaccination
#68Compositions and methods for inhibition of retroviruses
#69Formulations comprising aminosterols
#70Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof
#71COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF RETROVIRAL INFECTION
#72Recombinant IgG4 monovalent antibodies
#73ARTIFICIAL CALIBRATION VIRUS TO CONTROL HIV VIRAL LOAD TESTS BY PCR IN REAL TIME
#74COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF RETROVIRAL INFECTION
#75Parapoxviruses in combination with other antiviral agents for the treatment of viral diseases
#76Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitors
#77Methods and compositions related to the structure and function of APOBEC3G
#78Method of determining immune enhancement of virus infectivity using Fc receptor-transfected cell lines
#79Methods and compositions for the synergistic activation of latent HIV
#80Effect of TULA on HIV
#81Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence
#82Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef
#83COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
#84Method of Inducing Neutralizing Antibodies to Human Immunodeficiency Virus
#85Polyamino acid for use as adjuvant
#86Pharmaceutical composition for the prophylaxis and treatment of HIV infection and its use
#87Human semen enhancer of viral infection peptides (SEVI) and their use
#88METHODS FOR TREATING HIV INFECTED SUBJECTS
#89Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
#90Polyamino acid for use as adjuvant
#91Vaccine design methodology
#92Anti HIV-1 bacterial and baculovirus recombinant Epap-1
#93Vaccination with immuno-isolated cells producing an immunomodulator
#94Generation of potent dominant negative transcriptional inhibitors
#95Method of inducing neutralizing antibodies to human immunodeficiency virus
#96Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodies
#97Dual functional oligonucleotides for use as anti-viral agents
#98Clinical method for the immunomodulatory and vaccine adjuvant use of poly-ICLC and other dsRNAs
#99Compositions comprising a first agent which provides a primary activation signal to T cells and a second agent which stimulates an accessory molecule on the surface of T cells
#100Methods for selectively enriching TH1 and TH2 cells
#101Therapeutic retroviral vectors for gene therapy
#102Vaccination with immuno-isolated cells producing an immunomodulator
#103Methods for treating HIV infected subjects
#104Methods, of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof